cBrain A/S (CBRAIN)
Nasdaq Copenhagen · Denmark · prices in DKK · close of 27 Oct 2026
Key indicators
| Last close | DKK 99.80 |
|---|---|
| 52-week range | 47.25 – 169.20 |
| Return, 1 month / 3 months | +46.3% / +93.0% |
| Return, 1 year / 3 years | −37.3% / −43.0% |
| Trend | Uptrend |
| RSI (14) | 82 |
| Volatility (1 year) | 57.9% |
| Worst drawdown (1 year) | -70.8% |
| Average daily value traded | 5.66M DKK |
| Dividend yield | 1.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
cBrain A/S develops and supplies software for digital case handling and workflow management. Its main product is a platform used by public authorities to manage cases, documents and processes, and the company also offers related consulting and support services. Customers are chiefly government agencies and municipalities, with the company based in Denmark and serving public-sector organisations that need structured, digital administration tools.
On this site cBrain A/S appears as a stock on the Nasdaq Copenhagen (Denmark), code CBRAIN, with prices in Danish kroner (DKK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
cBrain A/S (CBRAIN) trades on the Nasdaq Copenhagen in Denmark. It last closed at DKK 99.80 on 27 October 2026.
Its price-based Market X-Ray is 50 out of 100 (a fair price profile), ranking 89 of 164 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 37.3% and over the last three months it rose 93.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Copenhagen
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 66 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 50.2% | ||
| From 52-week high | -38.3% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 93.0% | ||
| 6-month return | 48.0% | ||
| 12-month return, skipping the last month | -57.2% | ||
| Stability (higher is calmer) | 9 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 57.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -70.8% | ||
| Liquidity | 72 · Strong | Trades actively. | |
| Average daily value traded | 5.66M DKK | ||
| Zero-volume days | 0.0% | ||
| Income | 40 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.0% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +28.6% |
|---|---|
| 1 month | +46.3% |
| 3 months | +93.0% |
| 6 months | +48.0% |
| 1 year | −37.3% |
| 3 years | −43.0% |
| 5 years | −70.8% |
Signals
| 50-day / 200-day average | 75.42 / 66.43 |
|---|---|
| Golden / death cross (60 days) | Golden, 12 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.34 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Apr 2026 | DKK 1.0000 |
| 30 Apr 2025 | DKK 0.6400 |
| 25 Apr 2024 | DKK 0.2800 |
| 20 Apr 2023 | DKK 0.2100 |
| 29 Apr 2022 | DKK 0.1700 |
| 22 Apr 2021 | DKK 0.1400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Copenhagen; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.